Palo Alto, CA, United States of America

Roshanne Malekmadani

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2020 - 2021)
  • Los Angeles, CA (US) (2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Roshanne Malekmadani: Innovator in Glucose Monitoring Technology

Introduction

Roshanne Malekmadani is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of medical technology, particularly in glucose monitoring systems. With a total of 5 patents to her name, her work is paving the way for advancements in noninvasive health monitoring.

Latest Patents

Malekmadani's latest patents include a miniaturized noninvasive glucose sensor and a continuous glucose monitoring system. These systems utilize a photoacoustic sensor to estimate analyte concentration levels. Additionally, she has developed training methods for enhancing the accuracy of analyte sensors based on received acoustic signals. Another notable patent involves a test system for measuring fluid delivery, which includes a test housing designed to measure the volume of fluid dispensed by a fluid infusion device.

Career Highlights

Roshanne Malekmadani is currently employed at Medtronic Minimed, Inc., where she continues to innovate in the field of medical devices. Her work has been instrumental in improving the accuracy and efficiency of glucose monitoring technologies.

Collaborations

Throughout her career, Malekmadani has collaborated with notable professionals in her field, including Edward C. Morrow and Carl A. Link. These collaborations have further enhanced her contributions to medical technology.

Conclusion

Roshanne Malekmadani is a trailblazer in the development of glucose monitoring systems, with her innovative patents significantly impacting the medical technology landscape. Her dedication to improving health monitoring solutions continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…